Immune checkpoint inhibition and targeted therapy for melanoma: A patient‐oriented cross‐sectional comparative multicentre study-Reference-Cited by-同舟云学术

Immune checkpoint inhibition and targeted therapy for melanoma: A patient‐oriented cross‐sectional comparative multicentre study

Published:2022-12-07 Issue:5 Volume:37 Page:884-893
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Thiem Alexander¹^ORCID,Mashhadiakbar Pegah¹,Cussigh Christiane²,Hassel Jessica C.²,Grimmelmann Imke³,Gutzmer Ralf³⁴,Schlaak Max⁵⁶,Heppt Markus V.⁷^ORCID,Dücker Pia⁸,Hüning Svea⁸,Schulmeyer Lena⁹,Schilling Bastian⁹^ORCID,Haferkamp Sebastian¹⁰,Ziemer Mirjana¹¹^ORCID,Moritz Rose K. C.⁶¹²,Hagelstein Victoria¹³,Terheyden Patrick¹³,Posch Christian¹⁴¹⁵¹⁶^ORCID,Gaiser Maria R.¹⁷¹⁸,Kropp Peter¹⁹,Emmert Steffen¹,Müller Britta¹⁹,Tietze Julia K.¹^ORCID

Affiliation:

1. Clinic and Policlinic for Dermatology and Venereology University Medical Center Rostock Rostock Germany

2. Department of Dermatology, National Center for Tumor Diseases (NCT) Heidelberg University Hospital Heidelberg Germany

3. Department of Dermatology, Skin Cancer Center Hannover Hannover Medical School Hannover Germany

4. Department of Dermatology, Skin Cancer Center Minden Johannes‐Wesling‐Klinikum Minden/Ruhr‐University Bochum, Minden Germany

5. Department of Dermatology and Allergy University Hospital of Munich (LMU) Munich Germany

6. Department of Dermatology, Venereology and Allergology Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin Germany

7. Department of Dermatology, Comprehensive Cancer Center Erlangen‐European Metropolitan Area of Nuremberg (CCC ER‐EMN) Universitätsklinikum Erlangen, Friedrich‐Alexander‐University Erlangen‐Nürnberg Erlangen Germany

8. Department of Dermatology Hospital of Dortmund Dortmund Germany

9. Department of Dermatology, Venereology and Allergology University Hospital Würzburg Würzburg Germany

10. Department of Dermatology University Hospital Regensburg Regensburg Germany

11. Department of Dermatology, Venereology and Allergology University Medical Center Leipzig Leipzig Germany

12. Department of Dermatology and Venereology Martin‐Luther‐University Halle‐Wittenberg Halle (Saale) Germany

13. Department of Dermatology, Allergology, and Venereology University of Lübeck Lübeck Germany

14. Department of Dermatology, Venereology and Allergology Clinic Hietzing, Vienna Healthcare Group Vienna Austria

15. Department of Dermatology and Allergy, School of Medicine, German Cancer Consortium (DKTK) Technical University of Munich Munich Germany

16. Faculty of Medicine Sigmund Freud University Vienna Vienna Austria

17. Department of Dermatology, Venerology and Allergology, Medical Faculty Mannheim, University Medical Center Mannheim Heidelberg University Mannheim Germany

18. Skin Cancer Unit German Cancer Research Center (DKFZ) Heidelberg Germany

19. Institute of Medical Psychology and Medical Sociology University Medical Center Rostock Rostock Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18778

Reference34 articles.

1. A decade of immune-checkpoint inhibitors in cancer therapy

2. Melanoma

3. The systemic treatment of melanoma;Terheyden P;Dtsch Arztebl Int,2019

4. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019

5. Targeted and immunotherapies in BRAF mutant melanoma: where we stand and what to expect

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Side effects, quality of life, and treatment adherence in melanoma patients undergoing systemic therapy;Die Onkologie;2023-07-05

2. Advanced melanoma—A curable disease? Implications of systemic treatment on patients' daily life;Journal of the European Academy of Dermatology and Venereology;2023-04-13